TABLE 4.
Tissue-specific protein synthesis rates.
| Saliva | Serum | Between-Group Differences (P Value) | |||
|---|---|---|---|---|---|
| n | Mean ± SD | Mean ± SD | Saliva | Serum | |
| Muscle FSR (%·d−1) | |||||
| Low | 15 | 1.47 ± 0.21 | 1.21 ± 0.17 | 0.484 | 0.379 |
| High | 15 | 1.42 ± 0.16 | 1.16 ± 0.10 | ||
| Total | 30 | 1.45 ± 0.18 | 1.19 ± 0.14 | ||
| Prostate FSR (%·d−1) | |||||
| Low | 15 | 2.74 ± 0.70 | 2.25 ± 0.60 | 0.685 | 0.623 |
| High | 15 | 2.64 ± 0.58 | 2.16 ± 0.46 | ||
| Total | 30 | 2.69 ± 0.63 | 2.20 ± 0.52 | ||
| Prostate tumor FSR (%·d−1) | |||||
| Low | 15 | 4.76 ± 1.23 | 3.89 ± 0.97 | 0.905 | 0.885 |
| High | 15 | 4.72 ± 0.80 | 3.85 ± 0.55 | ||
| Total | 30 | 4.74 ± 1.02 | 3.87 ± 0.77 | ||
Values are mean ± SD. The columns “Saliva” and “Serum” present the tissue-specific protein synthesis rates as calculated with body water enrichment and serum-free [2H]alanine enrichment as a precursor pool, respectively.
Low, low physical activity group; High, high physical activity group.